Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448694 · ClinicalTrials.gov registry record
Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss
A clinical trial of Hemorrhage, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 320
- Enrollment target
- 1
- Study location
NCT01448694: Completed study of Hemorrhage, sponsored by University of Colorado, Denver.
NCT01448694 is a study of Hemorrhage that has completed, run by University of Colorado, Denver. The registered enrollment target is 320 participants, above the 251-participant average among 20 other Hemorrhage trials with a reported enrollment target (27% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01448694, a study of Hemorrhage, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is part of a Phase II STTR project to develop an algorithm called CipherSensor to apply feature extraction and machine learning techniques to non-invasive hemodynamic data to identify early signs of acute blood loss. The availability of this information may help to establish required interventions for treating trauma patients and battlefield casualties. Study hypothesis: Hemodynamic changes measured non-invasively during the blood donation process can be modeled to provide early estimations of blood loss.
Primary Outcome
Mathematical model of early blood loss
Conditions Studied
Interventions
- OTHER No treatment
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-09 |
What the finished NCT01448694 record still lists
NCT01448694 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, above the 251-participant average among 20 other Hemorrhage trials with a reported enrollment target (27% higher).
The record links to 1 condition, with Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which No treatment is the first listed.
NCT01448694 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01448694 about?
NCT01448694 is a clinical study titled "Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss". This study is part of a Phase II STTR project to develop an algorithm called CipherSensor to apply feature extraction and machine learning techniques to non-invasive hemodynamic data to identify early signs of acute blood loss. The availability of this information may help to establish required inte...
What is the current status of trial NCT01448694?
This trial is currently completed. The enrollment target is 320 participants. The study started on 2011-11. Estimated completion is 2014-09.
What conditions does trial NCT01448694 study?
This clinical trial studies the following conditions: Hemorrhage.
What interventions are being tested in trial NCT01448694?
The interventions under investigation include: No treatment (OTHER).
Who is sponsoring clinical trial NCT01448694?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01448694 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01448694's enrollment target sits among peer trials
320 5th of 20 higher than 16 of 20 other Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
RECRUITING · Phase 2
-
NIRS Monitoring in Premature Infants
RECRUITING
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
RECRUITING · Phase 4
-
The Effect of Fluids on Aortic VTI During C-section
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia